Searched for
GLENMARK PHARMACEUTICALS Q3 REVENUE
For investors looking beyond the short-term horizon: 5 mid-cap stocks from different sectors with upside potential up to 28%All is once again quiet on the US-Iran war front, and some kind of dialogue to resolve the issues between the two seems to be still underwa...
UTI Mutual Fund buys nearly 15 lakh shares of MCX for Rs 425 croreUTI Mutual Fund has significantly boosted its stake in MCX, acquiring nearly 15 lakh shares for a substantial Rs 425 crore via an open mark...
Maruti Suzuki shares jump 5% after Jefferies upgrades rating to Buy. Here's the latest target priceMaruti Suzuki shares rose nearly 5% after Jefferies upgraded the stock to ‘Buy’ and raised its target price to Rs 16,500, citing strong pas...
Nifty IT hits fresh 52-week low as Infosys, TCS, Wipro & others tumble up to 3%. What's spooking investors?The Nifty IT index fell more than 2% to a fresh 52-week low on Tuesday as persistent inflation concerns and uncertainty over the US Federal...
HAL announces final dividend of Rs 10 for FY26. Check record date and other detailsHAL has declared a final dividend of Rs 10 per share (200%) for FY26, subject to shareholder approval at the upcoming AGM. The record date ...
Twinkle Papers IPO opens for subscription today. Check GMP, price band and other detailsRetail investors can bid for a minimum of 4,000 shares, requiring an investment of Rs 2.76 lakh at the upper end of the price band. Novus C...
Q1 earnings preview: Here’s what Nomura expects from Nestle, Titan, other consumer majors’ June quarter resultsNomura expects consumer staples to deliver a strong start to FY27, forecasting double-digit sales growth for several companies in the June ...
Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
Buy, Sell or Hold: Goldman Sachs maintains sell on Bharat Dynamics; HDFC Securities maintains buy on IndiaMART InterMESHBrokerages remain divided on two stocks. Goldman Sachs retained its 'Sell' rating on Bharat Dynamics, raising the target price marginally t...
India's services exports narrow gap with goods trade as overall trade grows 5.4% in Q4FY26: NITI AayogIndia's trade saw a healthy 5.4% growth in Q4 FY26, driven by robust services exports that significantly boosted the services trade surplus...
Meesho shares rise 2% as Citi initiates coverage with Buy rating. Here's whyInternational brokerage Citi initiated coverage on Meesho with a 'Buy' rating, setting a target price of Rs 210 and anticipating a 23% upsi...
Bharat Electronics shares in focus after defence PSU wins orders worth Rs 1,081 croreBharat Electronics shares are in focus following a significant Rs 1,081 crore order win, adding to previous gains. The defence PSU reported...
Cochin Shipyard shares fall 3% amid buzz around OFS at 8% discountCochin Shipyard shares dipped Monday following reports of a potential government Offer for Sale (OFS) at a discount. The government, aiming...
Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
Accenture logs $18 billion Q3 revenue, revenue misses estimatesAccenture's Q3 FY26 results revealed a slowdown in IT demand, with the company missing revenue estimates and lowering its full-year guidanc...